FDA

FDA Clears Path For Abortion Pills At Pharmacies

FDA Clears Path For Abortion Pills At Pharmacies Laurel Duggan on January 3, 2023 The Food and Drug Administration (FDA) will allow pharmacies to dispense the abortion-inducing drug mifepristone, the agency announced…

A2 Milk jumps before halt on FDA nod news, denies report

Novavax says U.S. FDA clears COVID vaccine doses for release

Former CEO of Drug Manufacturing Company Pleads Guilty to Conspiring to Defraud the FDA and Distributing Adulterated Drugs

U.S. FDA advisers back Moderna COVID-19 vaccine for small children

Pfizer COVID vaccines safe and effective for small children, FDA staff say

FDA requires disclosure of suicide risk for anti-baldness drug

Novavax shares jump as FDA panel backs COVID vaccine

FDA withdraws approval for TG Therapeutics cancer treatment

FDA presses pause on trial for OTC version of anti-impotence drug Cialis

Biden has confidence in the FDA and its commissioner, White House says

Reckitt working with FDA on expediting baby formula imports from Mexico

U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccines

FDA To Relax Baby Formula Import Rules Amid Shortage

Joe Biden’s FDA Commissioner Says There is No Baby Formula Shortage

FDA Finds No Evidence of Bacteria at Shuttered Baby Formula Facility that Sparked Crisis

FDA declines to authorize common antidepressant as COVID treatment

Imported infant formula could help lift U.S. supply in weeks -FDA chief

U.S. FDA commissioner to testify about infant formula before House panel next week

U.S. FDA moves forward with proposal to ban menthol cigarettes

Pfizer to start U.S. trial of gene therapy as FDA lifts hold

FDA warns websites illegally selling ADHD drug Adderall

PEREGRINE VENTURES REALIZES USD 500 MILLION EXIT FROM CARTIHEAL FOLLOWING FDA APPROVAL OF IMPLANT FOR TREATMENT OF CARTILAGE AND OSTEOCHONDRAL DEFECTS USA – English USA – English

Former CEO of Drug Manufacturing Company Charged with Conspiring to Defraud the FDA and Distributing Adulterated Drugs

FDA Roundup: April 1, 2022

FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma